<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35028775</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>A novel homozygous mutation in TBK1 gene causing ALS-FTD.</ArticleTitle><Pagination><StartPage>2101</StartPage><EndPage>2104</EndPage><MedlinePgn>2101-2104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05820-z</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Libonati</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4323-3598</Identifier><AffiliationInfo><Affiliation>Rare Neuromuscular Diseases Centre, Department of Human Neurosciences, Sapienza University, Viale dell'universit&#xe0; 30, 00185, Rome, Italy. laura.libonati@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceccanti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rare Neuromuscular Diseases Centre, Department of Human Neurosciences, Sapienza University, Viale dell'universit&#xe0; 30, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cambieri</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rare Neuromuscular Diseases Centre, Department of Human Neurosciences, Sapienza University, Viale dell'universit&#xe0; 30, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colavito</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research &amp; Innovation S.R.L. (R&amp;I Genetics), 35127, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moret</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rare Neuromuscular Diseases Centre, Department of Human Neurosciences, Sapienza University, Viale dell'universit&#xe0; 30, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorini</LastName><ForeName>Ilenia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rare Neuromuscular Diseases Centre, Department of Human Neurosciences, Sapienza University, Viale dell'universit&#xe0; 30, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inghilleri</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rare Neuromuscular Diseases Centre, Department of Human Neurosciences, Sapienza University, Viale dell'universit&#xe0; 30, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C403191">TBK1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35028775</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05820-z</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05820-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539(7628):197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D (2016) The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol 138:225&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802973-2.00013-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston CA et al (2006) Amyotrophic lateral sclerosis in an urban setting. J Neurol 253(12):1642&#x2013;1643</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0195-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94&#x2013;102</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A, Al-Chalabi A (2021) The genetic architecture of ALS. Neurobiol Dis 147:105156</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G et al (2020) ALS genetics: gains, losses, and implications for future therapies. Neuron 108(5):822&#x2013;842</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney EM, Ahmed RM, Hodges JR (2019) Frontotemporal dementia. Handb Clin Neurol 167:279&#x2013;299</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-804766-8.00015-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves CV, Rohrer JD (2019) An update on genetic frontotemporal dementia. J Neurol 266(8):2075&#x2013;2086</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09363-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahheydari H et al (2017) Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum. Front Mol Neurosci 10:119</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00119</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi L et al (2017) mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation. J Neurol Neurosurg Psychiatry 88(10):869&#x2013;875</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316174</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34(6):404&#x2013;423</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC, Collins MO (2017) TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 10(1):5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxon JA et al (2020) The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener 21(7&#x2013;8):606&#x2013;613</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1797090</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi L et al (2017) TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation. J Neurol Neurosurg Psychiatry 88(10):869&#x2013;875</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316174</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassano M et al (2021) Mutational analysis of known ALS genes in an Italian population-based cohort. Neurology 96(4):e600&#x2013;e609</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011209</ArticleId></ArticleIdList></Reference><Reference><Citation>Larabi A et al (2013) Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep 3(3):734&#x2013;746</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.01.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18(5):631&#x2013;636</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I et al (2015) Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology 85(24):2116&#x2013;2125</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002220</ArticleId></ArticleIdList></Reference><Reference><Citation>Swift IJ et al (2021) Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature. Neurobiol Aging 99:100.e9-100.e15</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnood B, Ullgren A, Laffita-Mesa J, &#xd6;ijerstedt L, Patra K, Nennesmo I, Graff C&#xa0;(2021) TBK1 haploinsufficiency results in changes in the K63-ubiquitination profiles in brain and fibroblasts from affected and presymptomatic mutation carriers. J Neurol. https://doi.org/10.1007/s00415-021-10887-x</Citation></Reference><Reference><Citation>van der Zee J et al (2017) TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum Mutat 38(3):297&#x2013;309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23161</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM, Miller N, Ma YC (2016) Impaired autophagy and defective mitochondrial function: converging paths on the road to motor neuron degeneration. Front Cell Neurosci 10:44</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00044</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V et al (2020) The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice. Neuron 106(5):789-805.e5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A et al (2017) Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol 74(1):110&#x2013;113</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3712</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>